Research Partners Forums
Research Partners Forums are open dialogues among leaders in academia, business, government, non-profits and the public on subjects related to improving health through research.
Even as dozens of elections across the nation remained undecided or subject to recounts, it was clear that a divided Congress – and a divided nation – would have a significant impact on the future of medical and scientific research. Research!America’s Post-Election Briefing on November 8, at the American Association for the Advancement of Science (AAAS) in Washington, D.C.
“Oral health is often overlooked and undervalued,” according to Research!America’s Director of Policy and Programs Sara Chang who opened a Capitol Hill briefing on the topic October 10, 2018. A panel of experts explored issues related to how oral health is connected to systemic health, the need for more research, and policy issues that can help increase understanding of oral health.
More must be done to ensure robust funding for research that is focused on diseases with disproportionate impact, like migraine. During a panel discussion hosted by Research!America on October 3, 2018 on Capitol Hill, speakers called for more research and workplace accommodations for the 40 million Americans living with migraine.
Stigma remains a top barrier to treatment for mental illness among minority groups, said panelists during a Capitol Hill briefing hosted by Research!America, the Patient-Centered Outcomes Research Institute (PCORI), the National Hispanic Medical Association (NHMA) and the National Medical Association on June 13, 2018.
Flu pandemics and other disease outbreaks underscore the need for vaccines and public health infrastructures to protect individuals against global health threats, said leaders representing government, scientific societies and advocacy groups at a briefing hosted by Research!America and the American Society for Microbiology (ASM) at the Newseum in Washington, D.C. on May 21.
Fostering strong partnerships between clinicians and researchers is the key to speeding the discovery and implementation of new asthma treatments, said Judith Woodfolk, MBChB, Ph.D., professor of medicine, Division of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia School of Medicine, during Research!America’s asthma research briefing in Washington, D.C. on May 15.
When Grace Anne Dorney Koppel was diagnosed with chronic obstructive pulmonary disease (COPD), a progressive disease that makes it hard to breathe, her doctors told her she had 3-5 years to live. She had that conversation with her doctor nearly two decades ago. Today, she is a passionate advocate for COPD research and treatment. Noting that COPD patients have had the same treatments for 30 years, Koppel said “the clock is ticking and we cannot breathe.”
The percentage of working-age civilians in West Virginia who are employed has dropped below 50% for the first time in decades, partly due to a steep rise in opioid addiction across the state, said Senator Joe Manchin (D-W.Va.) during Research!America’s program “West Virginia Research and Innovation: A Catalyst for Better Health and Economic Growth” on October 16 at Shepherd University. Sen.
Of the top 10 causes of death in the U.S., Alzheimer’s disease is the only condition without a cure, treatment or means of prevention. More than five million Americans live with Alzheimer’s today, and the number is expected to triple by 2050.
Stronger partnerships between the public and private sector would help ensure patients have access to new medicines as a result of new discoveries. In a keynote speech at Research!America’s National Health Research Forum on September 7 in Washington, D.C., Mikael Dolsten, M.D., president of worldwide research & development, Pfizer, said the U.S. is a leader in worldwide R&D but sustained funding levels for the National Institutes of Health (NIH) and a regulatory system built for the 21st century are critical to build on our success.